Tap a claim on the ring to put it at the centre.
← Investment will keep draining out of cell and gene therapy until…
17 connected korrents · 17 moments from 21 Oct 1999 to 18 Sept 2026.
Everything filed under venture capital
venture capital
Everything filed under network science
network science
Everything filed under AI and science
AI and science
Everything filed under infrastructure
infrastructure
Everything filed under investing
investing
Everything filed under innovation
innovation
Everything filed under politics
politics Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Read this korrent: Investment will keep draining out of cell and gene therapy until manufacturing and regulatory risk become possible to underwrite. Investment will keep draining out of cell and gene therapy until manufacturing and regulatory risk become possible to underwrite. Last stated 4 months ago
10 Jun 2026
RT
Ruxandra Teslo — holds since 2026-06-10 — tap for who they are
Same subject: Manufacturing and batch-release requirements, not biology, are what kill most promising cell and gene therapies. — tap to centre the map on it Manufacturing and batch-release requirements, not biology, are what kill most promising cell and gene therapies. Last stated 4 months ago
10 Jun 2026
RT
Ruxandra Teslo — holds since 2026-06-10 — tap for who they are
Same subject: AI infrastructure companies that sell tools rather than drugs can become massive, highly valuable businesses in biotech. — tap to centre the map on it AI infrastructure companies that sell tools rather than drugs can become massive, highly valuable businesses in biotech. Last stated 11 months ago
23 Nov 2025
EH
Elliot Hershberg — holds since 2025-11-23 — tap for who they are
Same subject: If AI investment pulled back, the capital and resources involved would shift to other productive uses rather than sit idle. — tap to centre the map on it If AI investment pulled back, the capital and resources involved would shift to other productive uses rather than sit idle. Last stated a month ago
10 Sept 2026
MY
Matthew Yglesias — holds since 2026-09-10 — tap for who they are
Same subject: AI will not on its own compress decades of medical progress into a few years, because the binding constraint is human data, clinical trials and regulation rather than intelligence. — tap to centre the map on it AI will not on its own compress decades of medical progress into a few years, because the binding constraint is human data, clinical trials and regulation rather than intelligence. Last stated 3 months ago
21 Jul 2026
RT
Ruxandra Teslo — holds since 2026-07-21 — tap for who they are
JT
Jacob Trefethen — holds since 2025-08-02 — tap for who they are
Same subject: The biotech industry has not undergone the same exhaustive search for every commercializable opportunity that followed the internet's growth boom. — tap to centre the map on it The biotech industry has not undergone the same exhaustive search for every commercializable opportunity that followed the internet's growth boom. Last stated 2 years ago
16 Feb 2025
EH
Elliot Hershberg — holds since 2025-02-16 — tap for who they are
Same subject: No technology, including drug discovery technologies, is immune to the eventual pull toward commoditization. — tap to centre the map on it No technology, including drug discovery technologies, is immune to the eventual pull toward commoditization. Last stated 2 years ago
16 Mar 2025
EH
Elliot Hershberg — holds since 2025-03-16 — tap for who they are
Same subject: Nuclear plants should be financed with venture equity rather than project finance, because what is left is technology-execution risk and American venture capital is the best in the world at underwriting that. — tap to centre the map on it Nuclear plants should be financed with venture equity rather than project finance, because what is left is technology-execution risk and American venture capital is the best in the world at underwriting that. Last stated 2 months ago
15 Aug 2026
IT
Isaiah Taylor — holds since 2026-08-15 — tap for who they are
Same subject: The AI industry's near-term trajectory is driven more by finance and politics than by the underlying technology. — tap to centre the map on it The AI industry's near-term trajectory is driven more by finance and politics than by the underlying technology. Last stated a month ago
18 Sept 2026
RS
Robin Sloan — holds since 2026-09-18 — tap for who they are
Same subject: A first-time founder has an advantage over a repeat winner, because past success makes it too easy to raise money and hire against a big vision before there is product-market fit. — tap to centre the map on it A first-time founder has an advantage over a repeat winner, because past success makes it too easy to raise money and hire against a big vision before there is product-market fit. Last stated 4 months ago
14 Jun 2026
MP
Mark Pincus — holds since 2026-06-14 — tap for who they are
Same subject: A founder should take half the valuation if it buys all of the control, because the right to be wrong in your own way is what founding was for. — tap to centre the map on it A founder should take half the valuation if it buys all of the control, because the right to be wrong in your own way is what founding was for. Last stated 5 months ago
2 Jun 2026
MP
Mark Pincus — holds since 2026-06-02 — tap for who they are
Same subject: About 5% is the most common final ownership stake for the founder of a VC-funded startup that works out. — tap to centre the map on it About 5% is the most common final ownership stake for the founder of a VC-funded startup that works out. Last stated 3 months ago
18 Jul 2026
PL
Pieter Levels — holds since 2026-07-18 — tap for who they are
Same subject: Being unable to raise venture capital is not a tragedy for a business. — tap to centre the map on it Being unable to raise venture capital is not a tragedy for a business. Last stated 7 years ago
8 Jun 2019
TG
Tren Griffin — holds since 2019-06-08 — tap for who they are
Same subject: Only a fifth of venture-backed founders are still CEO three years after going public, and the standard documents their lawyers gave them are why. — tap to centre the map on it Only a fifth of venture-backed founders are still CEO three years after going public, and the standard documents their lawyers gave them are why. Last stated 5 months ago
10 May 2026
ER
Eric Ries — holds since 2026-05-10 — tap for who they are
Same subject: Silicon Valley's intolerance of dissent functions as a kind of soft Leninism. — tap to centre the map on it Silicon Valley's intolerance of dissent functions as a kind of soft Leninism. Last stated 10 months ago
1 Jan 2026
DW
Dan Wang — holds since 2026-01-01 — tap for who they are
Same subject: A system built from ordinary, mundane components can still give rise to genuine higher-level collective organization, as with ant colonies and pheromone chemistry. — tap to centre the map on it A system built from ordinary, mundane components can still give rise to genuine higher-level collective organization, as with ant colonies and pheromone chemistry. Last stated 2 months ago
31 Aug 2026
VR
Venkatesh Rao — holds since 2026-08-31 — tap for who they are
Same subject: Because two generic mechanisms reproduce the observed distributions, large networks are governed by self-organizing rules that do not depend on what the network is made of. — tap to centre the map on it Because two generic mechanisms reproduce the observed distributions, large networks are governed by self-organizing rules that do not depend on what the network is made of. Last stated 27 years ago
21 Oct 1999
RA
Réka Albert — holds since 1999-10-21 — tap for who they are
AB
Albert-László Barabási — holds since 1999-10-21 — tap for who they are
Same subject: Large real-world networks share one property: the number of connections per node follows a scale-free power law. — tap to centre the map on it Large real-world networks share one property: the number of connections per node follows a scale-free power law. Last stated 27 years ago
21 Oct 1999
RA
Réka Albert — holds since 1999-10-21 — tap for who they are
AB
Albert-László Barabási — holds since 1999-10-21 — tap for who they are
At the centre
Investment will keep draining out of cell and gene therapy until manufacturing and regulatory risk become possible to underwrite.
Holds Read this korrent →
Manufacturing and batch-release requirements, not biology, are what kill most promising cell and gene therapies.
Holds
AI infrastructure companies that sell tools rather than drugs can become massive, highly valuable businesses in biotech.
Holds
If AI investment pulled back, the capital and resources involved would shift to other productive uses rather than sit idle.
Holds
AI will not on its own compress decades of medical progress into a few years, because the binding constraint is human data, clinical trials and regulation rather than intelligence.
Holds
The biotech industry has not undergone the same exhaustive search for every commercializable opportunity that followed the internet's growth boom.
Holds
No technology, including drug discovery technologies, is immune to the eventual pull toward commoditization.
Holds
Nuclear plants should be financed with venture equity rather than project finance, because what is left is technology-execution risk and American venture capital is the best in the world at underwriting that.
Holds
The AI industry's near-term trajectory is driven more by finance and politics than by the underlying technology.
Holds
A first-time founder has an advantage over a repeat winner, because past success makes it too easy to raise money and hire against a big vision before there is product-market fit.
Holds
A founder should take half the valuation if it buys all of the control, because the right to be wrong in your own way is what founding was for.
Holds
About 5% is the most common final ownership stake for the founder of a VC-funded startup that works out.
Holds
Being unable to raise venture capital is not a tragedy for a business.
Holds
Only a fifth of venture-backed founders are still CEO three years after going public, and the standard documents their lawyers gave them are why.
Holds
Silicon Valley's intolerance of dissent functions as a kind of soft Leninism.
Holds
A system built from ordinary, mundane components can still give rise to genuine higher-level collective organization, as with ant colonies and pheromone chemistry.
Holds
Because two generic mechanisms reproduce the observed distributions, large networks are governed by self-organizing rules that do not depend on what the network is made of.
Holds
Large real-world networks share one property: the number of connections per node follows a scale-free power law.
Holds